Back to Search Start Over

Enhanced sulfate pseudo-affinity chromatography using monolith-like particle architecture for purifying SARS-CoV-2.

Authors :
Kadoi K
Toba J
Uehara A
Isoda N
Sakoda Y
Iwamoto E
Source :
Vaccine [Vaccine] 2025 Mar 03; Vol. 53, pp. 126951. Date of Electronic Publication: 2025 Mar 03.
Publication Year :
2025
Publisher :
Ahead of Print

Abstract

Traditional virus chromatographic purification face limitations owing to the small pore sizes of conventional resins, which restrict efficient virus binding. The newly developed MLP1000 DexS, a cellulose monolith-like particle (MLP) with large continuous pores (radius of 1.5 μm) and a sulfate pseudo-affinity ligand, facilitates virus access to intraparticle surfaces and significantly enhances binding capacity. In this study, we investigated the effectiveness of MLP1000 DexS for purifying severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) from Vero cells. Using a 0.29 mL column volume, we evaluated this resin through bind-elute mode chromatography under two load volume conditions (4.5 mL and 21 mL). MLP1000 DexS exhibited superior performance under high-loading conditions, achieving a high elution recovery of 59 % for the virus compared with that of 11-17 % for the commercial resins Cellufine Sulfate and Capto DeVirS. Additionally, the dsDNA removal capacity of MLP1000 DexS was 3.0-5.3-fold higher than that of the other resins. These findings suggest that MLP1000 DexS is an effective purification material for the downstream processing of live-attenuated and inactivated coronavirus vaccine production.<br />Competing Interests: Declaration of competing interest The authors declare the following financial interests/personal relationships that may be considered as potential competing interests: K.K., J.T., A.U., and E.I. are employees of the JNC Corporation, which manufactures Cellufine chromatography resins and cellulose resin MLP.<br /> (Copyright © 2024. Published by Elsevier Ltd.)

Details

Language :
English
ISSN :
1873-2518
Volume :
53
Database :
MEDLINE
Journal :
Vaccine
Publication Type :
Academic Journal
Accession number :
40037125
Full Text :
https://doi.org/10.1016/j.vaccine.2025.126951